Vor Biopharma Q2 Adj. EPS Misses Estimate
Vor Biopharma reports Q2 adjusted EPS of $(0.80), missing the $(0.70) estimate
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.